Role for mucosal immune responses and cell‐mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus*
- 24 May 2002
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 67 (3) , 384-393
Abstract
Venezuelan equine encephalitis virus (VEEV) replicates in lymphoid tissues following peripheral inoculation and a high titre viraemia develops. Encephalitis develops after the virus enters the central nervous system from the blood, with the earliest neuronal involvement being via the olfactory nerve. Following aerosol challenge with virulent VEEV, the virus is thought to replicate in the nasal mucosa and there could be direct entry into the olfactory nerve via infected neuroepithelial cells. Protection from VEEV infection is believed to be primarily mediated by virus specific antibody. The correlation between protection and neutralising serum antibody titres is, however, inconsistent when the virulent virus is administered by the airborne route. This study demonstrates a link between antibody in serum and the nasal mucosa and protection by means of passive immunisation studies. Intra-nasal administration of antibody increased protection against airborne virus in Balb/c mice. Vaccination of μMT strain mice that do not have functional B cells and cannot produce antibody revealed normal proliferation of spleen cells in vitro and robust cytokine production. Aerosol challenge of μMT mice demonstrated that complete protection was only achieved when passive immunisation with antibody was supplemented with active immunisation with the TC-83 vaccine strain of the virus. This implies that cell-mediated immune functions are required for protection against airborne challenge with virulent VEEV. J. Med Virol. 67:384–393, 2002. Copyright © Crown Copyright 2002. Recorded with the permission of the controller of Her Majesty's Stationery Office. Published by Wiley-Liss, Inc.Keywords
This publication has 37 references indexed in Scilit:
- An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccineVaccine, 2000
- Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccineVaccine, 1998
- Improved Protection against Venezuelan Equine Encephalitis by Genetic Engineering of a Recombinant Vaccinia VirusViral Immunology, 1998
- Kinetics of Cytokine Expression and Regulation of Host Protection Following Infection with Molecularly Cloned Venezuelan Equine Encephalitis VirusVirology, 1997
- Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN miceVaccine, 1997
- Mucosal Immunity Induced by Parenteral Immunization with a Live Attenuated Venezuelan Equine Encephalitis Virus Vaccine CandidateVirology, 1997
- Mechanism of Neuroinvasion of Venezuelan Equine Encephalitis Virus in the MouseVirology, 1995
- Specific Restrictions in the Progression of Venezuelan Equine Encephalitis Virus-Induced Disease Resulting from Single Amino Acid Changes in the GlycoproteinsVirology, 1995
- TC‐83 Venezuelan equine encephalitis vaccine exposure during pregnancyTeratology, 1987
- Live, Attenuated Venezuelan Equine Encephalomyelitis Virus VaccineThe American Journal of Tropical Medicine and Hygiene, 1967